Abstract: Atherogenesis and restenosis are treated by long term administration of physiologically acceptable compounds which enhance the level of endogenous nitric oxide in the host. Alternatively, or in combination, other compounds may be administered which provide for short term enhancement of nitric oxide, either directly or by physiological processes. In addition, cells may be genetically engineered to provide a component in the synthetic pathway to nitric oxide, so as drive the process to enhance nitric oxide concentration, particularly in conjunction with the administration of a nitric oxide precursor.
Type:
Grant
Filed:
June 11, 1993
Date of Patent:
June 27, 1995
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
John P. Cooke, Victor J. Dzau, Gary H. Gibbons
Abstract: A process for the preparation of vitamin A which preferably comprises bringing cyclogeranyl sulphone into contact with a C.sub.10 aldehyde acetal, halogenating the derivative obtained and then removing the halogen group and the sulphone, removing the acetal group and isomerizing the retinal obtained to the desired configuration. Also disclosed are compounds useful as intermediates in the synthesis of vitamin A and processes for preparation of these intermediate compounds.
Abstract: A process for producing dichloroacetaldehyde hydrate together with chloral from acetaldehyde or para-aldehyde. The process comprises a step of chlorinating acetaldehyde or para-aldehyde to obtain a chlorinated solution containing dichloroacetaldehyde as a major component, a step of distilling this chlorinated solution to obtain a distillate having a boiling point of 90.degree.-100.degree. C. and containing 50% or more of dichloroacetaldehyde, a step of adding water to this distillate, crystallizing dichloroacetaldehyde hydrate, and separating the crystals, and a step of chlorinating the remaining aldehyde components into chloral. The process enables dichloroacetaldehyde hydrate to be separated at a high purity and the raw materials to be utilized efficiently.
Abstract: Phenols are reacted with a hydrogen peroxide in the presence of a crystalline titanosilicate catalyst and a cyclic ether, such as dioxane, as a solvent. The method provides especially high para-selectivity compared with conventional methods, and, at the same time, provides high yields of dihydric phenols versus hydrogen peroxide.
Type:
Grant
Filed:
May 2, 1994
Date of Patent:
June 20, 1995
Assignee:
Mitsubishi Gas Chemical Company, Inc.
Inventors:
Ryuji Sugai, Osamu Kondo, Yuki Motoyama, Shu Yoshida
Abstract: A process for purifying vitamin A consisting of heating a vitamin A preparation in an inert atmosphere, at a temperature below 170.degree. C. and a pressure of less than 4 mm of mercury, said heating taking place in a vessel shielded from light is disclosed. The vitamin A obtained from this process is mixed with from 0.5:1 to 2:1 parts of tocopherol to vitamin A. The vitamin A and tocopherol mixture can be encapsulated in acacia gum, starch, pectins or other suitable materials. Other antioxidants can be added.
Type:
Grant
Filed:
August 3, 1994
Date of Patent:
June 20, 1995
Assignee:
The Procter & Gamble Company
Inventors:
Robert J. Sarama, Michael R. Sevenants, Robert A. Sanders
Abstract: A method for producing an aldehyde, which comprises reacting an olefin with carbon monoxide and hydrogen in a hydroformylation reaction zone in the presence of a rhodium catalyst having an organophosphorus compound as a ligand, wherein a reaction solution withdrawn from the hydroformylation reaction zone, which contains an unreacted olefin, an aldehyde product and the catalyst, is countercurrently contacted with carbon monoxide and hydrogen in a contact tower to separate and recover the unreacted olefin without substantially deactivating the rhodium catalyst and supplying the recovered unreacted olefin together with the carbon monoxide and the hydrogen to the hydroformylation reaction zone.
Abstract: A phenol is produced by reacting an aromatic compound with oxygen and hydrogen in the liquid phase in the presence of a catalyst comprising a noble metal of group VIII of the periodic table, which is supported on a carrier, and in the co-presence of a vanadium compound. The reaction is carried out either (i) by using as the catalyst a catalyst containing 0% to 0.15% by weight, based on the weight of the catalyst, of halogens, or (ii) further in the co-presence of a diketone compound of the following formula (1) or (2): ##STR1## wherein R.sup.1 and R.sup.
Abstract: An improved process for the preparation of 1,6-dibromo-2 -naphthol is disclosed. The improvement is accomplished by carrying out the reaction in an organic solvent at a temperature of from about 40.degree. to about 60.degree. C. in the presence of a catalytically-effective amount of a compound of the formula: ##STR1## where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and are alkyl, cycloalkyl, phenyl, substituted phenyl, naphthyl, substituted naphthyl heteroaryl, substituted heteroaryl or R.sub.1 taken together with R.sub.2 and the nitrogen atom form a heteroaryl or substituted heteroaryl group in which the heteroatom is nitrogen and X is an inorganic anion.
Abstract: A pharmaceutical composition having improved stability which comprises a fumagillol derivative and a fatty acid ester of glycerin or polyglycerin is disclosed. The composition is useful for treating diseases associated with angiogenesis such as hepatoma, etc.
Abstract: An optically active tri-substituted methane compound having, as substituents, an aromatic ring group and a phenyl group having hydroxyl group at ortho or para position can be obtained by allowing a phenol compound unsubstituted at the ortho- or/and para-position to react with an optically active secondary carbinol compound having an aromatic ring group at the alpha-position in the presence of tri-substituted phosphine and diazodicarboxylate or diazodicarboxamide. These and other optically active tri-substituted methane compounds are useful as active ingredients for medicines or as intermediate compounds for preparing medicines.
Abstract: The present invention provides a process for preparing optically active 2-arylcyclohexanol and its esters and ethers and which process comprises the step of subjecting 1-aryl-cyclohexane-1,2 diol and its diethers and diesters to hydrogenolysis conditions to form said cyclohexanol and its esters and ethers.
Abstract: 4-Halo-1-naphthol is reacted with a secondary amine and formaldehyde to produce a reaction mixture containing a Mannich base which is hydrogenated to produce 2-methyl-1-naphthol. Advantageously, the procedure can be carried out in one pot.
Type:
Grant
Filed:
October 8, 1993
Date of Patent:
May 30, 1995
Assignee:
Clairol, Inc.
Inventors:
Mu-Ill Lim, Linas Stasaitis, Yuo-Guo Pan, Alexander Chan
Abstract: The production of cis-dihydrodiol compounds of the formula ##STR1## where n is 0 or 1 (preferably 0) by the microbial oxidation of a diphenylaceylene compound of the formula ##STR2## using a mutant of a Pseudomonas bacteria at 25.degree. to 35.degree. C. and pH 6-8 is disclosed. The cis-dihydrodiol compound is in turn treated with an aqueous solution of a base to produce a corresponding 3-hydroxydiphenylacetylene compound or with an aqueous solution of an acid to produce a corresponding 2-hydroxyacetylene compound.
Abstract: The co-formation of diarylalkane by-product in the chloroalkylation of an aromatic compound with an aldehyde is minimized by conducting the reaction in a continuous manner in a concentration with agitation and in the presence of both hydrogen sulfate and hydrogen chloride.
Type:
Grant
Filed:
July 18, 1994
Date of Patent:
May 30, 1995
Assignee:
Albemarle Corporation
Inventors:
R. Carl Herndon, Jr., Gary D. Focht, Karl R. Jones
Abstract: A process for producing 2-formyl-1,4-butanediol comprises effecting reaction of 2-butene-1,4-diol with hydrogen and carbon monoxide in the presence of:(a) a rhodium compound,(b) a tris(substituted aryl) phosphite having an electronic parameter, .nu.-value, of 2,080 to 2,090 cm.sup.-1 and a steric parameter, .theta.-value, of 135.degree. to 190.degree. and being represented by the formula P(OR).sub.3wherein each of R's, which may be the same or different, represents a substituted aryl group having at least 7 carbon atoms, and(c) a bis (diphenylphosphino) alkane represented by the formula Ph.sub.2 P-(CH.sub.2)n-PPh.sub.2 where n n is an integer of 2 to 6, andat a temperature of not more than 80.degree. C.
Abstract: o-Dihydroxylated aromatic compounds, for example pyrocatechol, are selectively prepared by reacting an o-fuchsone with an oxidizing agent, for example hydrogen peroxide, optionally in the presence of a catalytically effective amount of an acid catalyst.
Type:
Grant
Filed:
January 10, 1994
Date of Patent:
May 9, 1995
Assignee:
Rhone-Poulenc Chimie
Inventors:
Michel Costantini, Daniel Manaut, Daniel Michelet
Abstract: A process for manufacturing monochloroacetaldehyde trimer and chloral together by effectively utilizing a raw material acetaldehyde or para-aldehyde. The process comprises a step of chlorinating acetaldehyde or para-aldehyde to produce a chlorinated liquid of which the major component is monochloroacetaldehyde, a step comprising adding chloral to said chlorinated liquid and distilling the mixture to obtain a fraction of which the major components are monochloroacetaldehyde and chloral, a step of trimerizing monochloroacetaldehyde by reacting said fraction in the presence of a trimerization catalyst and separating the MCA trimer by filtration, and a step of chlorinating other fractions from said distillation step and the filtrate from said trimerization step to produce chloral. According to this process all raw material aldehydes and components derived from aldehydes which have not been consumed for the production of MCA trimer can be easily converted into chloral which is useful as an industrial chemical.
Abstract: 4,4'-Dihydroxy-alpha-alkylstilbenes of high purity are prepared by reacting at a temperature of from about -20.degree. C. to about 20.degree. C. a mixture of (1) at least one alpha-haloketone, (2) at least one phenolic hydroxyl-containing compound or alkoxy-containing aromatic compound, and (3) at least one strong protonic acid or Lewis acid; such that the mole ratio of phenolic hydroxyl-containing compound or alkoxy-containing aromatic compound:alpha-haloketone(s) is from 0.1:1 to 1.9:1, and the mole ratio of phenolic hydroxyl-containing compound or alkoxy-containing aromatic compound:alpha-haloketone(s):strong protonic acid or Lewis acid is from about 0.1:1:0.0026 to about 1.9:1:0.95. The high purity 4,4'-dihydroxy-alpha-alkylstilbenes are useful for the advancement of epoxy resins, for the preparation of phenoxy resins and for the preparation of epoxy resins.
Type:
Grant
Filed:
December 3, 1993
Date of Patent:
May 9, 1995
Assignee:
The Dow Chemical Company
Inventors:
Robert E. Hefner, Jr., Maria I. Villarreal, David A. Carr
Abstract: A process is described for the production of cyclohexanedimethanol by hydrogenation of a dialkyl cyclohexanedicarboxylate which comprises the steps of:(a) providing a hydrogenation zone containing a charge of a granular reduced manganese promoted copper catalyst;(b) forming a vaporous feed stream of a hydrogenatable material comprising a dialkyl cyclohexanedicarboxylate and from about 0.1 wt % up to about 15 wt % of an acidic material at a feed temperature which is in the range of from about 150.degree. C. to about 350.degree. C. and which is above the dew point of the feed stream and at a feed pressure which is in the range of from about 150 psia (about 10.34 bar) up to about 2000 psia (about 137.
Abstract: A method is provided for making bisphenol by condensing a ketone and a phenol in the presence of a sulfonated aromatic organic polymeric ion-exchange catalyst having aminoorganomercaptan groups using a phenol having less than 1 ppm of hydroxyacetone.